RAPT Therapeutics
RAPT58.0200.00% ( 0.000 )
RAPT Therapeutics (RAPT)
RAPT Therapeutics, Inc. operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercializatio...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 58.020
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 58.020
- Volume Ratio
- 0.00
- Turnover Ratio
- --
RAPT Therapeutics Analyst Rating
View MoreForecast & Rating
Feb 20, 2026Price forecast
$58.00-0.03%
Forecast & RatingHold
9analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- prnewswire · 2 days ago, 09:32 AM
10:31 ETFood Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight
- Tip Ranks · May 18 at 06:05 PM
Analyst Lifts RAPT Therapeutics Price Target to $56 and Reiterates Buy on RAP-219 Seizure Data Upside
- nasdaq · Mar 15 at 05:35 PM
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share
- Market Beat · Mar 5 at 12:44 AM
Rapt Therapeutics (NASDAQ:RAPT) Receives Average Rating of "Hold" from Analysts
- Tip Ranks · Mar 3 at 08:37 AM
RAPT Therapeutics Completes Acquisition and Transitions to Private Ownership
- Market Beat · Feb 13 at 08:41 AM
Rapt Therapeutics (NASDAQ:RAPT) Sees Large Growth in Short Interest
